{'fraction_non_alphanumeric': 0.024896265560165973, 'fraction_numerical': 0.005532503457814661, 'mean_word_length': 5.308139534883721, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
ACCC Institute Envisions Next Gen Multidisciplinary Cancer Care

54 accc-cancer.org | September–October 2017 | OI On June 22, 2017, ACCC invited stakeholders from a variety of disciplines to step away from the pressures and demands of daily business and come together in Washington, D.C., to envision next gen multidisciplinary cancer care. Facilitating this ACCC Institute for the Future of Oncology forum was Kavita Patel, MD, MS, FACP, a nonresident fellow at the Brookings Institution and practicing primary care internist at Johns Hopkins Medicine. In my inaugural column in Oncology Issues, I described why I believe it’s critical for those of us in oncology to pause and consider what our future multidisciplinary cancer care will look like. Each day, the imperative grows stronger as we continue the trek toward value-based care. As we imagine, anticipate, and prepare for future cancer care delivery, we must also assess what is required to move from today’s provider-focused, siloed care models to a future in which care is organized around the patient and the disease. Exciting advances in our understanding of cancer are revealing more subtypes and subtleties of the diseases known as cancer; as a result, anti-cancer therapies are becoming increasingly complex. New technologies and new therapies are already shaping next gen multidisciplinary cancer care, requiring that oncology expand to include new specialties and new collaborations to effectively diagnosis and deliver precision, patient-centered therapies. For participants in this year’s Institute—and for all of us involved in oncology—the shape of multidisciplinary cancer care is evolving as cancer therapies becomes more complex. At the same time, our health system is struggling through a metamorphosis, moving incrementally toward new payment models focused on value for all stakeholders (patients, payers, providers, and ultimately our society). We challenged Institute participants to imagine what next gen multidisciplinary care will look like—no small task. We also asked that they frame their vision through the multifaceted lens of new payment models and patient-centered care delivery.